N6-methyladenosine RNA modification regulates microglial phagocytosis in the APP/PS1 mouse model of Alzheimer’s disease
Genes Immun (2025). DOI: 10.1038/s41435-025-00347-1
Investigating the Interactions of a Cyclic Peptide Hormone Somatostatin and Its Derivatives on Amyloid-Beta Aggregation
ACS Chem. Neurosci. 2025, XXXX, XXX, XXX-XXX DOI: 10.1021/acschemneuro.5c00044
ApoE3 Christ church and tau interaction as a protective mechanism against Alzheimer’s disease
Alzheimer’s & Dementia (2025), 21 (7), e70396 DOI: 10.1002/alz.70396
Lipid mediated formation of antiparallel aggregates in cerebral amyloid angiopathy
Acta Neuropathol 150, 3 (2025). DOI: 10.1007/s00401-025-02911-5
Synaptic enrichment of pSer129 alpha-synuclein correlates with dopaminergic denervation in early-stage Parkinson’s disease
Nat Commun 16, 6630 (2025). DOI: 10.1038/s41467-025-61052-1
The tau isoform 1N4R confers vulnerability of MAPT knockout human iPSC-derived neurons to amyloid beta and phosphorylated tau-induced neuronal dysfunction
Alzheimer’s Association 12, (2025). DOI: 10.1002/alz.14403
α-Synuclein fibrils enhance HIV-1 infection of human T cells, macrophages and microglia
Nat Commun 16, 813 (2025). DOI: 10.1038/s41467-025-56099-z
Tau aggregation induces cell death in iPSC-derived neurons
Aging Brain (2025) 7, 100136 DOI: 10.1016/j.nbas.2025.100136
Soluble tau aggregates decrease the threshold for thalamic oscillations and increase the excitability of thalamic neurons
Neuropharmacology (2025) 273, 110455 DOI: 10.1016/j.neuropharm.2025.110455
Early increase of the synaptic blood marker β-synuclein in asymptomatic autosomal dominant Alzheimer's disease
Alzheimers Dement (2025) 21 (4), e70146 DOI: 10.1002/alz.70146